You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Concerta

Showing 26 - 50 of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ADHD, ADHD Trial in New York (fMRI scans, Atomoxetine arm, Methylphenidate arm)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • ADHD
  • fMRI scans
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 7, 2020

Traumatic Brain Injury, TBI, ADHD Trial in Cincinnati (Methylphenidate, Placebo)

Completed
Has Results
  • Traumatic Brain Injury
  • +2 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jun 2, 2020

Attention Deficit/Hyperactivity Disorder Medications in Japan

Completed
  • Attention Deficit Disorder With Hyperactivity
  • MPH (Concerta)
  • +3 more
  • Titusville, New Jersey
    Janssen Investigative Site
Jan 21, 2020

Epilepsy Trial in Miami, New York, Portland (Methylphenidate, Placebo)

Not yet recruiting
  • Epilepsy
  • Miami, Florida
  • +2 more
Jun 4, 2020

Attention Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder Trial in Tel Hashomer

Terminated
  • Attention Deficit/Hyperactivity Disorder
  • +2 more
  • Tel Hashomer, Israel
    Sheba medical center
Mar 17, 2020

ADHD Trial in New Haven (Mindfulness-Based ADHD Treatment for Children, Goal-Standard Medication (Treatment as Usual))

Recruiting
  • Attention Deficit Hyperactivity Disorder
  • Mindfulness-Based ADHD Treatment for Children
  • Goal-Standard Medication (Treatment as Usual)
  • New Haven, Connecticut
    Clinical & Affective Neuroscience Lab
Jun 14, 2022

Neuropsychological, Genetic and Neuroimaging Markers and

Unknown status
  • Attention Deficit Disorder With Hyperactivity
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 2, 2019

Personality and Drug Use (PDU)

Withdrawn
  • Personality
    • (no location specified)
    Apr 23, 2022

    ADHD Trial in Worldwide (Lisdexamfetamine Dimesylate (LDX), Methylphenidate Hydrochloride, Placebo)

    Completed
    Has Results
    • ADHD
    • Lisdexamfetamine Dimesylate (LDX)
    • +2 more
    • Hoboken, Antwerp, Belgium
    • +48 more
    Jun 9, 2021

    Cancer Trial in Boston (methylphenidate, Placebo)

    Terminated
    Has Results
    • Cancer
    • Boston, Massachusetts
    • +1 more
    Apr 11, 2019

    Social Cognition Trial in Basel (3,4-Methylenedioxymethamphetamine, Methylphenidate, Placebo)

    Completed
    • Social Cognition
    • Basel, Switzerland
      University Hospital Basel
    Dec 10, 2018

    Epigenetics in ADHD

    Completed
    • microRNAs in Attention-deficit/Hyperactivity Disorder
      • Kaohsiung, Taiwan
        Liang-Jen Wang
      Apr 23, 2021

      ADHD (ADHD) Trial in Montreal (Academic and Organization skills, Parent Training, Social Skills Training)

      Unknown status
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Academic and Organization skills
      • +3 more
      • Montreal, Quebec, Canada
      • +1 more
      Aug 27, 2018

      Substance-Related Disorders Trial in Villejuif (Methylphenidate Pill)

      Withdrawn
      • Substance-Related Disorders
      • Methylphenidate Pill
      • Villejuif, France
        Hôpital Paul Brousse
      Jul 19, 2018

      ADHD (ADHD), Deficient Emotional Self-Regulation (DESR) Trial in Boston (ADHD Medication, Omega-3 Fatty Acids)

      Completed
      Has Results
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Deficient Emotional Self-Regulation (DESR)
      • ADHD Medication
      • Omega-3 Fatty Acids
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 28, 2018

      ADHD Trial in Montreal (methylphenidate or amphetamine product, Cognitive behavioral therapy)

      Unknown status
      • Attention Deficit Hyperactivity Disorder
      • methylphenidate or amphetamine product
      • Cognitive behavioral therapy
      • Montreal, Quebec, Canada
        Montreal Children's Hospital
      Aug 27, 2018

      ADHD Trial in Montreal (behavioral, other, drug)

      Unknown status
      • Attention Deficit Hyperactivity Disorder
      • Cognitive Behavioural & Skills Training
      • +3 more
      • Montreal, Quebec, Canada
        Montreal Children's Hospital
      Jul 30, 2018

      ADHD (ADHD) Trial in Montreal (Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine, Aerobic

      Unknown status
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine
      • Aerobic Exercise
      • Montreal, Quebec, Canada
        Montreal Children's Hospital
      Aug 13, 2018

      ADHD, Autism Spectrum Disorder Trial in Canada, United States (Randomization to either Amphetamine (AMP) class of stimulant

      Not yet recruiting
      • ADHD
      • Autism Spectrum Disorder
      • Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication
      • Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
      • Irvine, California
      • +11 more
      Jun 14, 2023

      ADHD Trial in New York (aripiprazole, Sugar pill)

      Terminated
      Has Results
      • Attention Deficit Hyperactivity Disorder
      • New York, New York
        New York State Psychiatric Institute
      Jun 18, 2020

      Attention Deficit/Hyperactivity Disorder Trial in Australia, Netherlands, United States (Short Acting Methylphenidate, Long

      Unknown status
      • Attention Deficit/Hyperactivity Disorder
      • Short Acting Methylphenidate
      • Long Acting Methylphenidate
      • Colton, California
      • +6 more
      Jul 9, 2018

      Breast Cancer, Fatigue, Gastrointestinal Cancer Trial in Houston (Methylphenidate, Placebo)

      Terminated
      Has Results
      • Breast Cancer
      • +2 more
      • Houston, Texas
        UT MD Anderson Cancer Center
      Dec 8, 2017

      Disruptive Mood Dysregulation Disorder Trial (MPH + APZ)

      Completed
      • Disruptive Mood Dysregulation Disorder
      • MPH + APZ
      • (no location specified)
      Nov 30, 2017

      ADHD Trial in Boston (L-methylfolate, OROS-Methylphenidate, Placebo)

      Completed
      Has Results
      • Attention Deficit Hyperactivity Disorder
      • Boston, Massachusetts
        Massachusetts General Hospital
      Oct 17, 2017

      Concerta (Methylphenidate) -To-Generic Switch Study

      Completed
      • Attention Deficit Disorder With Hyperactivity
      • Concerta
      • +2 more
      • (no location specified)
      Feb 10, 2017